Read + Share
Amedeo Smart
Independent Medical Education
Zhang S, Wang R, Wang X, Guo X, et al. HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer. J Biol Chem 2022 Jan 27:101644. doi: 10.1016/j.jbc.2022.101644.PMID: 35093383
Email
LinkedIn
Facebook
Twitter
Privacy Policy